Who are Senna alone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Senna tablets, Bisacodyl 5 milligram, Halflytely, Sodium picosulfate + magnesium citrate, polyethylene glycol, senna, Sodium Picosulfate/Magnesium Citrate Laxative.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/senna-alone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Senna alone — Competitive Intelligence Brief

Senna alone (Senna alone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Stimulant laxative. Area: Gastroenterology.

marketed Stimulant laxative Colonic smooth muscle and intestinal epithelium Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Senna alone (Senna alone) — Camlıca Erdem Hospital. Senna stimulates colonic muscle contractions and increases intestinal fluid secretion to promote bowel movements.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Senna alone TARGET	Senna alone	Camlıca Erdem Hospital	marketed	Stimulant laxative	Colonic smooth muscle and intestinal epithelium
Senna tablets	Senna tablets	Medtronic - MITG	marketed	Stimulant laxative	Colonic smooth muscle and intestinal epithelium
Bisacodyl 5 milligram	Bisacodyl 5 milligram	University of Nottingham	marketed	Contact laxative	Colonic smooth muscle and intestinal epithelium
Halflytely	BISACODYL	Braintree	marketed	Stimulant Laxative [EPC]	Kappa-type opioid receptor	2004-01-01
Sodium picosulfate + magnesium citrate	Sodium picosulfate + magnesium citrate	Parc de Salut Mar	marketed	Stimulant laxative + osmotic laxative combination
polyethylene glycol, senna	polyethylene glycol, senna	Children's Hospital of Philadelphia	marketed	Osmotic and stimulant laxative combination
Sodium Picosulfate/Magnesium Citrate Laxative	Sodium Picosulfate/Magnesium Citrate Laxative	American University of Beirut Medical Center	marketed	Osmotic and stimulant laxative combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Stimulant laxative class)

Camlıca Erdem Hospital · 1 drug in this class
Medtronic - MITG · 1 drug in this class
St. Joseph's Healthcare Hamilton · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Senna alone — Competitive Intelligence Brief. https://druglandscape.com/ci/senna-alone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab